
CV Sciences Investor Relations Material
Latest events

Q2 2025
CV Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CV Sciences Inc
Access all reports
CV Sciences Inc. is a life sciences company focused on developing and commercializing products derived from hemp-based cannabidiol (CBD). The company's offerings include consumer health products, such as dietary supplements and topical formulations, that promote wellness and support various health needs. CV Sciences operates through two primary segments: consumer products and drug development. The consumer products division produces CBD-based products under the PlusCBD brand, while the drug development segment is involved in researching CBD-based therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the OTCQB.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CVSI
Country
🇺🇸 United States